Abbott Laboratories Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
08/19

DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ rallied 2.09% to $112.68 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

The stock's rise snapped a two-day losing streak.

Abbott Laboratories closed 18.04% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Pfizer Inc. $(PFE)$ rose 1.41% to $27.25, and Merck & Co. Inc. $(MRK)$ fell 0.59% to $135.17.

Trading volume (9.7 M) remained 2.5 million below its 50-day average volume of 12.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10